IBS treatment app helps patients reprogram their minds
An IBS treatment app that facilitates cognitive behavior therapy helped trial participants manage symptoms and improve their quality of life.
MDMA for PTSD just crushed its phase 3 trial
Results from the first phase 3 trial of using MDMA for PTSD along with talk therapy found the drug to be effective.
Phase 2 trial finds psychedelic works as well as common drug
A small study has provided evidence of psilocybin for depression working as well as a popular SSRI.
NYU is launching a center for psychedelic medicine
NYU’s Center for Psychedelic Medicine will serve as the nexus for the school’s psychedelic research, as well as provide training to budding researchers.
Oral ketamine treatment reduced suicidal thoughts: Pilot study
A new, small study in Australia suggests that oral ketamine treatment may help treat suicidal thoughts.
Mount Sinai is opening a psychedelic research center
A pacesetting institution, the Icahn School of Medicine at Mount Sinai is opening a psychedelic research center focusing on MDMA and trauma.
Want better science? Learn how to lie (with magic).
Some experiment designs need to deceive. These former magicians have some advice.